Pharmacologic Thromboprophylaxis for Patients Admitted to General Medicine - Is It Necessary?


Journal

NEJM evidence
ISSN: 2766-5526
Titre abrégé: NEJM Evid
Pays: United States
ID NLM: 9918317485806676

Informations de publication

Date de publication:
Jun 2022
Historique:
medline: 1 6 2022
pubmed: 1 6 2022
entrez: 6 2 2024
Statut: ppublish

Résumé

Necessity of Pharmacologic ThromboprophylaxisIt is a busy night on call, with 15 new admissions to general internal medicine. The senior resident checks over the admission orders, including low-molecular-weight heparin for venous thromboembolism prophylaxis. The resident wonders: Does everyone admitted to general medicine really require pharmacologic thromboprophylaxis?

Identifiants

pubmed: 38319277
doi: 10.1056/EVIDtt2200085
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

EVIDtt2200085

Auteurs

Michael Fralick (M)

Division of General Internal Medicine, Department of Medicine, Sinai Health, Toronto.

Michelle Sholzberg (M)

Division of Hematology, Department of Medicine, St. Michael's Hospital, Toronto.

Classifications MeSH